Skip to main content
SpringerLink
Log in

Nutritional Care of Cancer Patients

  • Chapter
Surgery

Abstract

Nutrition plays a central role in cancer pathophysiology and therapy. Nutrition status has an important effect on quality of life and sense of well-being in cancer patients. Recent discoveries have highlighted the importance of nutritional factors in the carcinogenesis process and in cancer prevention. Cancer is frequently characterized as a ‘wasting disease,’ a vividly accurate term to patients, families, and clinicians dealing with cancer. The lay press and professional journals are replete with articles concerning the use of various nutrition interventions to treat, palliate, and support cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Warren S. The immediate cause of death in cancer. Am J Med Sci 1932; 185: 610–615.

    Google Scholar 

  2. Inagaki J, Rodriguez V, Bodey GP. Causes of death in cancer patients. Cancer 1974; 33: 568–573.

    PubMed  CAS  Google Scholar 

  3. Studley HO. Percentage of weight loss. JAMA 1936; 106: 458–460.

    Google Scholar 

  4. Dudrick SJ, Wilmore DW, Vars HM, Rhoads JE. Long-term total parenteral nutrition with growth, development and positive nitrogen balance. Surgery (St. Louis) 1968; 64: 134–142.

    CAS  Google Scholar 

  5. Copeland EM, MacFayden BV Jr, Dudrick S J. Intravenous hyperalimentation in cancer patients. J Surg Res 1974; 16: 241–247.

    PubMed  CAS  Google Scholar 

  6. Copeland EM. Intravenous hyperalimentation and cancer: a historical perspective [Jonathan E. Rhoads Lecture]. JPEN J Parenter Enteral Nutr 1986; 10: 337–342.

    Google Scholar 

  7. Klein S, Kinney J, Jeejeebhoy K, et al. Nutrition support in clinical practice: review of published data and recommendations for future research directions. JPEN J Parenter Enteral Nutr 1997; 21: 133–156.

    PubMed  CAS  Google Scholar 

  8. Kern KA, Norton JA. Cancer cachexia. JPEN J Parenter Enteral Nutr 1988; 12: 286–298.

    PubMed  CAS  Google Scholar 

  9. Brennan MF. Total parenteral nutrition in the cancer patient. N Engl J Med 1981; 305: 375–382.

    PubMed  CAS  Google Scholar 

  10. Kritchevsky SB, Wilcosky TC, Morris DL, et al. Changes in plasma lipid and lipoprotein cholesterol and weight prior to diagnosis of cancer. Cancer Res 1991; 51: 3198–3203.

    PubMed  CAS  Google Scholar 

  11. DeWys WD, Begg D, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 1980; 69: 491–497.

    PubMed  CAS  Google Scholar 

  12. DeWys WD. Anorexia as a general effect of cancer. Cancer 1972; 43: 2013–2019.

    Google Scholar 

  13. Ottery FD. Supportive nutrition to prevent cachexia and improve quality of life. Semin Oncol 1995; 22 (suppl 13): 98–111.

    PubMed  CAS  Google Scholar 

  14. Puccio M, Nathanson L. The cancer cachexia syndrome. Semin Oncol 1997; 24: 277–287.

    PubMed  CAS  Google Scholar 

  15. Ottery FD. Cancer cachexia: prevention, early diagnosis, and management. Cancer Prac 1994; 2: 123–131.

    CAS  Google Scholar 

  16. Albrect JT, Canada TW. Cachexia and anorexia in malignancy. Hematol Oncol Clin North Am 1996; 10: 791–800.

    Google Scholar 

  17. Lowry SF. Cancer cachexia revisisted: old problems and new perspectives [editorial]. Eur J Cancer 1991; 27: 1–3.

    PubMed  CAS  Google Scholar 

  18. Costa G, Bewley P, Aragon M, et al. Anorexia and weight loss in cancer patients. Cancer Treat Rep 1985; 65 (suppl 5): 3–7.

    Google Scholar 

  19. Tisdale MJ. Cancer cachexia: metabolic alterations and clinical manifestations. Nutrition 1997; 13: 1–7.

    PubMed  CAS  Google Scholar 

  20. Grosvenor M, Bulcavage L, Chlebowski RT. Symptoms potentially influencing weight loss in a cancer population: correlations with primary site, nutritional status, and chemotherapy administration. Cancer 1989; 63: 330–334.

    PubMed  CAS  Google Scholar 

  21. Chang AE, August DA. Acute abdomen, bowel obstruction, and fistula. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE eds. Clinical Oncology. New York: Churchill Livingstone, 1995; 101: 583–597.

    Google Scholar 

  22. Nelson KA, Walsh D, Sheehan FA. The cancer anorexia-cachexia syndrome. J Clin Oncol 1994; 12: 213–225.

    PubMed  CAS  Google Scholar 

  23. Falconer JS, Fearon KC, Plester CE, et al. Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg 1994; 219: 325–331.

    PubMed  CAS  Google Scholar 

  24. Hansell DT, Davies JW, Burns HJ. The relationship between resting energy expenditure and weight loss in benign and malignant disease. Ann Surg 1986; 203: 240–245.

    PubMed  CAS  Google Scholar 

  25. Arbeit JM, Lees DE, Corsey R, Brennan MF. Resting energy expenditure in controls and cancer patients with localized and diffuse disease. Ann Surg 1984; 199: 292–298.

    PubMed  CAS  Google Scholar 

  26. Knox LS, Crosby LO, Feurer ID, et al. Energy expenditure in malnourished cancer patients. Ann Surg 1983; 197: 152–162.

    PubMed  CAS  Google Scholar 

  27. Hyltander A, Drott C, Korner U, et al. Elevated energy expenditure in cancer patients with solid tumours. Eur J Cancer 1991; 27: 9–15.

    PubMed  CAS  Google Scholar 

  28. Norton JA, Moley JF, Green MV. Parabiotic transfer of cancer anorexia/cachexia in male rats. Cancer Res 1985; 45: 5547–55552.

    PubMed  CAS  Google Scholar 

  29. Stovroff MC, Fraker DL, Norton JA. Cachectin activity in the serum of cachectic, tumor bearing rats. Arch Surg 1989; 124: 94–99.

    PubMed  CAS  Google Scholar 

  30. Lind’DS, Souba WW, Copeland EM. Weight loss and cachexia. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE, eds. Clinical Oncology New York: Churchill Livingstone, 1995; 56: 393–407.

    Google Scholar 

  31. Beutler B, Mahoney J, LeTrang, et al. Purification of cachectin, a lipoprotein lipase suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. J Exp Med 1985; 161: 984–995.

    PubMed  CAS  Google Scholar 

  32. Garcia-Martinez C, Costelli P, Lopez-Soriano FJ, et al. Is TNF really involved in cachexia? Cancer Invest 1997; 15: 47–54.

    PubMed  CAS  Google Scholar 

  33. Tracey KJ, Wei H, Manogue KR, et al. Cachectin/TNF induces cachexia, anemia, and inflammation. J Exp Med 1988; 167: 1211–1227.

    PubMed  CAS  Google Scholar 

  34. Oliff A, Defeo-Jones D, Boyer M, et al. Tumors secreting human TNF/cachectin induce cachexia in mice. Cell 1987; 50: 555–563.

    PubMed  CAS  Google Scholar 

  35. Tracey KJ, Morgello S, Koplin B, et al. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production: cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia. J Clin Invest 1990; 86: 2014–2024.

    PubMed  CAS  Google Scholar 

  36. Tracey K, Vlassara H, Cerami A. Cachectin/tumor necrosis factor. Lancet 1989; 11: 1122–1126.

    Google Scholar 

  37. Toomey D, Redmond P, Bouchier-Hayes D. Mechanisms mediating cancer cachexia. Cancer 1995; 76: 2418–2426.

    PubMed  CAS  Google Scholar 

  38. Matthys P, Dijkmans S, Proost P, et al. Severe cachexia in mice inoculated with interferon-y producing tumor cells. Int J Cancer 1991; 49: 77–82.

    PubMed  CAS  Google Scholar 

  39. Langstein HN, Doherty GM, Fraker DL, et al. The role of in-terferon-y and tumor necrosis factor-« in an experimental rat model of cancer cachexia. Cancer Res 1991; 51: 2302–2306.

    PubMed  CAS  Google Scholar 

  40. Matthys P, Heremans H, Openakker G, et al. Anti-interferon-y antibody treatment, growth of Lewis lung tumors in mice and tumor associated cachexia. Eur J Cancer 1991; 27: 182–187.

    PubMed  CAS  Google Scholar 

  41. Fischer E, Marano MA, Barber AE, et al. Comparison between effects of interleukin-lalpha administration and sublethal en-dotoxemia in primates. Am J Physiol 1991; 261: 442–452.

    Google Scholar 

  42. Fong Y, Tracey KJ, Moldawer LL, et al. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and inter-leukin 6 appearance during lethal bacteremia. J Exp Med 1989; 170: 1627–1633.

    PubMed  CAS  Google Scholar 

  43. Gelin J, Moldawer LL, Lonnroth C, et al. Appearance of hy-bridoma growth factor/interleukin-6 in the serum of mice bearing a methylcholanthrene-induced sarcoma. Biochem Biophys Res Commun 1988; 157: 575–579.

    PubMed  CAS  Google Scholar 

  44. Espat NJ, Moldawer LL, Copeland EM. Cytokine-mediated alterations in host metabolism prevent nutritional repletion in cachectic cancer patients. J Surg Oncol 1995; 58: 77–82.

    PubMed  CAS  Google Scholar 

  45. Rofe AM, Bourgeosis CS, Coyle P, et al. Altered insulin response to glucose in weight-losing cancer patients. Anticancer Res 1994; 4: 647–650.

    Google Scholar 

  46. Morrison SD. Feeding response to tumor-bearing rats with insulin and insulin withdrawal and the contribution of autonomous tumor drain to cachectic depletion. Cancer Res 1982; 42: 3642–3647.

    PubMed  CAS  Google Scholar 

  47. Moley JF, Morrison SD, Norton JA. Insulin reversal of cancer cachexia in rats. Cancer Res 1985; 45: 4925–4931.

    PubMed  CAS  Google Scholar 

  48. Moley JF, Peacock JE, Morrison SD, et al. Insulin reversal in cancer induced protein loss. Surg Forum 1985; 36: 416–419.

    CAS  Google Scholar 

  49. Lundholm K, Holm G, Schersten T. Insulin resistance in patients with cancer. Cancer Res 1978; 38: 4665–4670.

    PubMed  CAS  Google Scholar 

  50. Holyrode CP, Gabuzda TG, Putnam RC, et al. Altered glucose metabolism in metastatic carcinoma. Cancer Res 1975; 35: 3710–3714.

    Google Scholar 

  51. Waterhouse C. Lactate metabolism in patients with cancer. Cancer 1974; 33: 66–71.

    PubMed  CAS  Google Scholar 

  52. Lundholm K, Edstrom S, Karlberg I, et al. Glucose turnover, glu-coneogenesis from glycerol, and estimation of net glucose cycling in cancer patients. Cancer 1982; 50: 1142–1150.

    PubMed  CAS  Google Scholar 

  53. Waterhouse C, Jeanpetre N, Keilson J. Gluconeogenesis from ala-nine in patients with progressive malignant disease. Cancer Res 1979; 39: 1968–1972.

    PubMed  CAS  Google Scholar 

  54. Mueller PS, Watkin DM. Plasma unesterified fatty acid concentration in neoplastic disease. J Lab Clin Med 1961; 57: 95–99.

    PubMed  CAS  Google Scholar 

  55. Kralovic RC, Zepp A, Canedella RJ. Studies of the mechanism of carcass fat depletion in experimental cancer. Eur J Cancer 1977; 13: 1071–1079.

    PubMed  CAS  Google Scholar 

  56. Shaw JHF, Wolfe RR. Fatty acid and glycerol kinetics in septic patients and patients with gastrointestinal cancer: the response to glucose infusion and parenteral feeding. Ann Surg 1987; 205: 368–376.

    PubMed  CAS  Google Scholar 

  57. Dilman VM, Berstein LM, Ostroumova MN, et al. Peculiarities of hyperlipidaemia in tumour patients. Br J Cancer 1981; 43: 637–643.

    PubMed  CAS  Google Scholar 

  58. Hussey HJ, Tisdale MJ. Effect of polyunsaturated fatty acids on the growth of murine colon adenocarinomas in vitro and in vivo. Br J Cancer 1994; 70: 6–10.

    PubMed  CAS  Google Scholar 

  59. Norton JA, Stein TP, Brennan MF. Whole body protein synthesis and turnover in normal man and malnourished patients with and without known cancer. Ann Surg 1981; 194: 123–128.

    PubMed  CAS  Google Scholar 

  60. Jeevanandam M, Legaspi A, Lowry SF, et al. Effect of total parenteral nutrition on whole body protein kinetics in cachectic patients with benign or malignant disease. JPEN J Parenter Enteral Nutr 1988; 12: 229–236.

    PubMed  CAS  Google Scholar 

  61. Lundholm K, Bylund AC, Holm J, et al. Skeletal muscle metabolism in patients with malignant tumor. Eur J Cancer 1976; 12: 465–473.

    PubMed  CAS  Google Scholar 

  62. Lundholm K, Bennegard K, Eden E, et al. Efflux of 3-methylhis-tidine from the leg in cancer patients who experience weight loss. Cancer Res 1982; 42: 4807–4811.

    PubMed  CAS  Google Scholar 

  63. Warren RS, Jeevanadam M, Brennan MF. Comparison of hepatic protein synthesis in vivo versus in vitro in the tumor-bearing rat. J Surg Res 1987; 42: 43–50.

    PubMed  CAS  Google Scholar 

  64. Fearon KCH, McMillan DC, Preston T, et al. Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer. Ann Surg 1991; 213: 26–31.

    PubMed  CAS  Google Scholar 

  65. Moldawer LL, Andersson C, Lonnroth C, et al. Mechanisms of hypoalbuminemia in experimental cancer. JPEN J Parenter Enteral Nutr 1987; 11: 38.

    Google Scholar 

  66. Moldawer LL, Rogy MA, Lowry SA. The role of cytokines in cancer cachexia. JPEN J Parenter Enteral Nutr 1992; 16: 43–49.

    Google Scholar 

  67. McNamara MJ, Alexander R, Norton JA. Cytokines and their role in the pathophysiology of cancer cachexia. JPEN J Parenter Enteral Nutr 1992; 16: 50–55.

    Google Scholar 

  68. Argiles JM, Alvarez B, Lopez-Soriano FJ. The metabolic basis of cancer cachexia. Med Res Rev 1997; 17: 477–498.

    PubMed  CAS  Google Scholar 

  69. Loprinzi CL, Schaid DJ, Burnham NL, et al. Body composition changes in patients who gain weight while receiving megestrol acetate. J Clin Oncol 1993; 11: 152–154.

    PubMed  CAS  Google Scholar 

  70. Simons JP, Aaronson NK, Vansteenkiste JF, et al. Effects of medroxyprogesterone on appetite, weight, and quality of life in advanced-stage non-hormone sensitive cancer: a placebo controlled multicenter study. J Clin Oncol 1996; 14: 1077–1084.

    PubMed  CAS  Google Scholar 

  71. Anonymous. More on megestrol for prevention and treatment of cancer-associated cachexia. Clin Oncol Alert 1998; 13: 21–22.

    Google Scholar 

  72. Tchekmedyian NS, Heber D. Cancer and AIDS cachexia: mechanisms and approaches to therapy. Oncol 1993; 7: 55–59.

    Google Scholar 

  73. Bartlett DL, Stein P, Torosian MH. Effect of growth hormone and protein intake on tumor growth and host cachexia. Surgery 1995; 117: 260–267.

    PubMed  CAS  Google Scholar 

  74. Wolf RF, Pearlstone DB, Newman E, et al. Growth hormone and insulin reverse net whole body and skeletal muscle protein ca-tabolism in cancer patients. Ann Surg 1992; 216: 280–290.

    PubMed  CAS  Google Scholar 

  75. Wadleigh R, Spaulding M, Lembersky B, et al. Dronabinol enhancement of appetite in cancer patients [abstract]. Proc Am Soc Clin Oncol 1990; 9: 1280.

    Google Scholar 

  76. Nelson KA, Walsh T, Deeter P, et al. A phase II study of delta- 9-tetrahydrocannabinol for appetite stimulation in cancer associated anorexia. J Pall Care 1994; 10: 14–19.

    CAS  Google Scholar 

  77. Gold J. Hydrazine sulfate: a current perspective. Nutr Cancer 1987; 9: 59–66.

    PubMed  CAS  Google Scholar 

  78. Chlebowski RT, Bulcavage L, Grosvenor M, et al. Hydrazine sulfate influence on nutritional status and survival in non-small-cell lung cancer. J Clin Oncol 1990; 8: 9–15.

    PubMed  CAS  Google Scholar 

  79. Kotsy MP, Fleishman SB, Herndon JE, et al. Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized, placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B. J Clin Oncol 1994; 12: 1113–1120.

    Google Scholar 

  80. Loprinzi CL, Goldberg RM, Su JQ, et al. Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small cell lung cancer. J Clin Oncol 1994; 12: 1126–1129.

    PubMed  CAS  Google Scholar 

  81. Loprinzi CL, Kuross SA, O’Fallon JR, et al. Randomized, placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer. J Clin Oncol 1994; 12: 1121–1125.

    PubMed  CAS  Google Scholar 

  82. Kardinal CG, Loprinzi CL, Schaid DJ, et al. A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia. Cancer 1990; 65: 2657–2662.

    PubMed  CAS  Google Scholar 

  83. Laviano A, Renvyle T, Yang Z-J. From laboratory to bedside: new strategies in the treatment of malnutrition in cancer patients. Nutrition 1996; 7: 112–122.

    Google Scholar 

  84. Lissoni P, Ardizzoia A, Perego MS, et al. Inhibition of tumor necrosis factor-alpha secretion by pentoxifylline in advanced cancer patients with abnormally high blood levels of tumor necrosis factor-alpha. J Biol Regul Homeost Agents 1993; 7: 73–75.

    PubMed  CAS  Google Scholar 

  85. Dezube BJ, Sherman ML, Fridovich-Keil JL, et al. Down-regulation of tumor necrosis factor expression by pentoxifylline in cancer patients: a pilot study. Cancer Immunol Immunother 1993; 36: 57–60.

    PubMed  CAS  Google Scholar 

  86. Goldberg RM, Loprnzi CL, Mailliard JA, et al. Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial. J Clin Oncol 1995; 13: 2856–2859.

    PubMed  CAS  Google Scholar 

  87. A.S.P.E.N. Board of Directors: Standards for nutrition support: hospitalized patients. Nutr Clin Pract 1995; 10: 208–218.

    Google Scholar 

  88. Hill GL. The perioperative patient. In: Kinney JM, Jeejeebhoy KN, Hill GL, Owen OE, eds. Nutrition and Metabolism in Patient Care. Philadelphia: Saunders, 1988: 643–655.

    Google Scholar 

  89. Smale BF, Mullen JL, Buzby GP, et al. The efficacy of nutritional assessment and support in cancer surgery. Cancer 1981; 47: 2375–2381.

    PubMed  CAS  Google Scholar 

  90. Buzby GP, Mullen JL, Mathews DC, et al. Prognostic nutritional index in gastrointestinal surgery. Am J Surg 1980; 139: 160–167.

    PubMed  CAS  Google Scholar 

  91. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. Perioperative total parenteral nutrition in surgical patients. N Engl J Med 1991; 325: 525–532.

    Google Scholar 

  92. Kirby DF, DeLegge MH. Nutritional assessment: the high tech and low tech tour. In: Kirby DF, Dudrick SJ, eds. Practical Handbook of Nutrition in Clinical Practice. Boca Raton: CRC Press, 1994: 1–18.

    Google Scholar 

  93. Detsky AS, McLaughlin JR, Baker JP, et al. What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr 1987; 11: 8–13.

    PubMed  CAS  Google Scholar 

  94. Baker JP, Detsky AS, Whitwell J, et al. Nutritional assessment: a comparison of clinical judgement and objective measurements. N Engl J Med 1982; 306: 969–972.

    PubMed  CAS  Google Scholar 

  95. Ottery FD. Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition 1996; 12: 15–19.

    Google Scholar 

  96. Ottery FD. Instruments of proactive assessment and intervention in the context of outcomes-based research and clinical care. In: Improving Clinical Practice with Nutrition in a Managed Care Environment. Columbus: Ross Products Division, Abbott Laboratories, 1997; 29–36.

    Google Scholar 

  97. Falconer JS, Fearon KCH, Ross JA, et al. Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer 1995; 75: 2077–2082.

    PubMed  CAS  Google Scholar 

  98. Deehan DJ, Heys SD, Walker LG, et al. Serum albumin: an independent prognostic factor in patients with colorectal cancer [abstract]. Br J Surg 1995; 82: 691.

    Google Scholar 

  99. Delmore G. Assessment of nutritional status in cancer patients: widely neglected? Support Care Cancer 1997; 5: 376–380.

    PubMed  CAS  Google Scholar 

  100. Bozzetti F. Effects of artificial nutrition on the nutritional status of cancer patients. JPEN J Parenter Enteral Nutr 1989; 13: 406–420.

    PubMed  CAS  Google Scholar 

  101. Goldstein AS, Elwun DH, Askanazi J. Functional and metabolic changes during feeding in gastrointestinal cancer. J Am Coll Nutr 1989; 8: 530–536.

    PubMed  CAS  Google Scholar 

  102. Lin M-T, Saito H, Fukushima R, et al. Preoperative total parenteral nutrition influences postoperative cytokine responses after colorectal surgery. Nutrition 1997; 13: 8–12.

    PubMed  CAS  Google Scholar 

  103. Daly JM, Thom AK. Neoplastic diseases. In: Kinney JM, Jeejeebhoy KN, Hill GL, Owen OE, eds. Nutrition and Metabolism in Patient Care. Philadelphia: Saunders, 1988: 567–587.

    Google Scholar 

  104. Torosian MH. Stimulation of tumor growth by nutrition support. JPEN J Parenter Enteral Nutr 1992; 16: 72S - 75S.

    PubMed  CAS  Google Scholar 

  105. Popp MB, Wagner SC, Brito OJ. Host and tumor responses to increasing levels of intravenous nutritional support. Surgery 1983; 94: 300–308.

    PubMed  CAS  Google Scholar 

  106. Torosian MH, Donoway RB. Total parenteral nutrition and tumor metastasis. Surgery 1991; 109: 597–601.

    PubMed  CAS  Google Scholar 

  107. Baron PL, Lawrence W, Chan WMY, et al. Effects of parenteral nutrition on cell cycle kinetics of head and neck cancer. Arch Surg 1986; 121: 1282–1286.

    PubMed  CAS  Google Scholar 

  108. Frank JL, Lawrence W Jr, Banks WL Jr, et al. Modulation of cell cycle kinetics in human cancer with total parenteral nutrition. Cancer 1992; 69: 1858–1864.

    PubMed  CAS  Google Scholar 

  109. Franchi F, Rossi-Fanelli F, Seminara P, et al. Cell kinetics of gastrointestinal tumors after different nutritional regimens: a preliminary report. J Clin Gastroenterol 1991; 13: 313–315.

    PubMed  CAS  Google Scholar 

  110. Heys SD, Park KGM, McNurlan MA, et al. Stimulation of protein synthesis in human tumours by parenteral nutrition: evidence for modulation of tumour growth. Br J Surg 1991; 78: 483–487.

    PubMed  CAS  Google Scholar 

  111. Klein S, Koretz RL. Nutritional support in patients with cancer: what do the data really show? Nutr Clin Pract 1994; 9: 91–100.

    PubMed  CAS  Google Scholar 

  112. Holter AR, Fischer JE. The effects of perioperative hyperalimentation on complications in patients with carcinoma and weight loss. J Surg Res 1977; 23: 33–41.

    Google Scholar 

  113. Sako K, Lore JM, Kaufman S, et al. Parenteral hyperalimentation in surgical patients with head and neck cancer: a randomized study. J Surg Oncol 1981; 16: 391–402.

    PubMed  CAS  Google Scholar 

  114. Muller JM, Brenner U, Dienst C, et al. Preoperative parenteral feeding in patients with gastrointestinal carcinoma. Lancet 1982; 1: 68–71.

    PubMed  CAS  Google Scholar 

  115. Yamada N, Koyama H, Hioka K, et al. Effect of postoperative total parenteral nutrition (TPN) as an adjunct to gastrectomy for advanced gastric carcinoma. Br J Surg 1983; 70: 267–274.

    PubMed  CAS  Google Scholar 

  116. Muller JM, Keller HW, Brenner U, et al. Indications and effects of preoperative parenteral nutrition. World J Surg 1986; 10: 53–63.

    PubMed  CAS  Google Scholar 

  117. Askanazi J, Hensle TW, Starker PM, et al. Effect of immediate postoperative nutritional support on length of hospitalization. Ann Surg 1986; 203: 236–239.

    PubMed  CAS  Google Scholar 

  118. Brennan MF, Pisters PW, Posner M, et al. A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy. Ann Surg 1994; 220: 436–444.

    PubMed  CAS  Google Scholar 

  119. Fan S-T, Lo C-M, Lai ECS, et al. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med 1994; 331: 1547–1552.

    PubMed  CAS  Google Scholar 

  120. Meijerink WJHJ, von Meyenfeldt MF, Rouflart MMJ, et al. Efficacy of peroperative nutritional support. Lancet 1992; 340: 187–188.

    PubMed  CAS  Google Scholar 

  121. Gianotti L, Braga M, Vignali A, et al. Effect of route of delivery and formulation of postoperative nutritional support in patients undergoing major operations for malignant neoplasms. Arch Surg 1997; 132: 1222–1230.

    PubMed  CAS  Google Scholar 

  122. Sagar S, Harland P, Shields R. Early postoperative feeding with elemental diet. Br Med J 1979; 1: 293–295.

    PubMed  CAS  Google Scholar 

  123. Smith RC, Hartemink RJ, Hollinshead JW, et al. Fine bore je-junostomy feeding following major abdominal surgery: a controlled, randomized trial. Br J Surg 1985; 72: 458–461.

    PubMed  CAS  Google Scholar 

  124. Foschi D, Cavagna G, Callioni F, et al. Hyperalimentation of jaundiced patients on percutaneous transhepatic biliary drainage. Br J Surg 1986; 73: 716–719.

    PubMed  CAS  Google Scholar 

  125. Heslin MJ, Latkany L, Leung D, et al. A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy. Ann Surg 1997; 226: 567–580.

    PubMed  CAS  Google Scholar 

  126. August DA. Creation of a specialized nutrition support outcomes research consortium: if not now, when? JPEN J Parenter Enteral Nutr 1996; 20: 394–400.

    PubMed  CAS  Google Scholar 

  127. Jordan WM, Valdivieso M, Frankmann C, et al. Treatment of advanced adenocarcinoma of the lung with ftorafur, doxorubicin, cyclophosphamide and cisplatin (FACP) and intensive IV hyperalimentation. Cancer Treat Rep 1981; 65: 197–205.

    PubMed  CAS  Google Scholar 

  128. Nixon DW, Moffitt S, Lawson DH, et al. Total parenteral nutrition as an adjunct to chemotherapy of metastatic colorectal cancer. Cancer Treat Rep 1981; 65 (suppl 5): 121–128.

    PubMed  Google Scholar 

  129. Popp MB, Fisher RI, Wesley R, et al. A prospective randomized study of adjuvant parenteral nutrition in the treatment of advanced diffuse lymphoma: influence on survival. Surgery 1981; 90: 195–203.

    PubMed  CAS  Google Scholar 

  130. Samuels ML, Selig DE, Ogden S, et al. IV hyperalimentation and chemotherapy for stage III testicular cancer: a randomized study. Cancer Treat Rep 1981; 65: 615–627.

    PubMed  CAS  Google Scholar 

  131. Serrou B, Cupissol D, Plagne R, et al. Follow-up of a randomized trial for oat cell carcinoma evaluating the efficacy of peripheral intravenous nutrition (PIVN) as adjunct treatment. Recent Results Cancer Res 1982; 80: 246–253.

    PubMed  CAS  Google Scholar 

  132. Shamberger RC, Brennan MF, Goodgame JT, et al. A prospective randomized study of adjuvant parenteral nutrition in the treatment of sarcomas: results of metabolic and survival studies. Surgery 1984; 96: 1–13.

    PubMed  CAS  Google Scholar 

  133. Tandon SP, Gupta SC, Sinha SN, et al. Nutritional support as an adjunct therapy of advanced cancer patients. Indian J Med Res 1984; 80; 180–188.

    PubMed  CAS  Google Scholar 

  134. Clamon GH, Feld R, Evans WK, et al. Effect of adjuvant central IV hyperalimentation on the survival and response to treatment of patients with small cell lung cancer: a randomized trial. Cancer Treat Rep 1985; 69: 167–177.

    PubMed  CAS  Google Scholar 

  135. Valdivieso M, Frankmann C, Murphy WK, et al. Long-term effects of intravenous hyperalimentation administered during intensive chemotherapy for small cell bronchogenic carcinoma. Cancer 1987; 59: 362–369.

    PubMed  CAS  Google Scholar 

  136. Evans WK, Nixon DW, Daly JM, et al. A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer. J Clin Oncol 1987; 5: 113–124.

    PubMed  CAS  Google Scholar 

  137. De Cicco M, Panarello G, Fantin D, et al. Parenteral nutrition in cancer patients receiving chemotherapy: effects on toxicity and nutritional status. JPEN J Parenter Enteral Nutr 1993; 17: 513–518.

    PubMed  Google Scholar 

  138. Klein S, Simes J, Blackburn GL. Total parenteral nutrition and cancer clinical trials. Cancer 1986; 58: 1378–1386.

    PubMed  CAS  Google Scholar 

  139. McGeer AJ, Detsky AS, O’Rourke KO. Parenteral nutrition in cancer patients undergoing chemotherapy: a meta-analysis. Nutrition 1990; 6: 233–240.

    PubMed  CAS  Google Scholar 

  140. Anonymous. Parenteral nutrition in patients receiving cancer chemotherapy: American College of Physicians. Ann Intern Med 1989; 110: 734–736.

    Google Scholar 

  141. Weisdorf SA, Lysne J, Wind D, et al. Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation (Baltimore) 1987; 43: 833–838.

    CAS  Google Scholar 

  142. Szeluga DJ, Stuart RK, Brookmeyer R, et al. Nutritional support of bone marrow transplant recipients: a prospective randomized clinical trial comparing total parenteral nutrition to an enteral feeding program. Cancer Res 1987; 47: 3309–3316.

    PubMed  CAS  Google Scholar 

  143. Ziegler TR, Young LS, Benfell K, et al. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. Ann Intern Med 1992, 116: 821–828.

    PubMed  CAS  Google Scholar 

  144. Schloerb PR, Amare M. Total parenteral nutrition with gluta-mine in bone marrow transplantation and other clinical applications (a randomized, double-blind study). JPEN J Parenter Enteral Nutr 1993; 17: 407–413.

    PubMed  CAS  Google Scholar 

  145. A.S.P.E.N. Board of Directors. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr 1993; 17: 12–13.

    Google Scholar 

  146. Donaldson SS. Nutritional support as an adjunct to radiation therapy. JPEN J Parenter Enteral Nutr 1984; 8: 302–310.

    PubMed  CAS  Google Scholar 

  147. Sikora AA, Ribeiro U, Kane JM, et al. Role of nutrition support during induction chemoradiation therapy in esophageal cancer. JPEN J Parenter Enteral Nutr 1998; 22: 18–22.

    PubMed  CAS  Google Scholar 

  148. Imoberdorf R. Immuno-nutrition: designer diets in cancer. Support Care Cancer 1997; 5: 381–386.

    PubMed  CAS  Google Scholar 

  149. Heys SD, Gough DB, Khan L, et al. Nutritional pharmacology and malignant disease: a therapeutic modality in patients with cancer. Br J Surg 1996; 83: 608–619.

    PubMed  CAS  Google Scholar 

  150. Souba WW. Glutamine and cancer. Ann Surg 1993; 218: 715–728.

    PubMed  CAS  Google Scholar 

  151. Hagmuller E, Gunther HJ, Brosicke H, et al. In vivo studies in man on anabolism of protein metabolism in malignant colon tumors: correlations to pathohistology. Am J Clin Nutr 12 (suppl 2):5–6.

    Google Scholar 

  152. O’Riordain MG, Fearon KCH, Ross JA, et al. Glutamine-supplemented total parenteral nutrition enhances T-lymphocyte response in surgical patients undergoing colorectal resection. Ann Surg 1994; 220: 212–221.

    PubMed  Google Scholar 

  153. Morlion BJ, Stehle P, Wachtier P, et al. Total parenteral nutrition with glutamine dipeptide after major abdominal surgery: a randomized, double blind, controlled study. Ann Surg 1998, 227: 302–308.

    PubMed  CAS  Google Scholar 

  154. Lacour J, Lacour F, Spira A, et al. Adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer: updated results of a randomised trial. Br Med J 1984; 288: 589–592.

    CAS  Google Scholar 

  155. Lacour J, Laplanche A, Delozier T, et al. Polyadenylic-polyuridylic acid plus locoregional and pelvic radiotherapy versus chemotherapy with CMF as adjuvants in operable breast cancer. Breast Cancer Res Treat 1991; 19: 15–22.

    PubMed  CAS  Google Scholar 

  156. Lacour J, Laplanche A, Malafosse M, et al. Polyadenylic-polyuridylic acid as an adjuvant in resectable colorectal carcinoma: a 6–1/2 year follow-up analysis of a multicentric double blind randomized trial. Eur J Surg Oncol 1992; 18: 599–604.

    PubMed  CAS  Google Scholar 

  157. Kenler AS, Swails WS, Driscoll DF, et al. Early enteral feeding in postsurgical cancer patients: fish oil structured lipid-based polymeric formula versus standard polymeric formula. Ann Surg 1996; 223: 316–333.

    PubMed  CAS  Google Scholar 

  158. Kernen M, Senkal M, Homann H-H, et al. Early postoperative enteral nutrition with arginine, omega-3 fatty acids and ribonucleic acid-supplemented diet versus placebo in cancer patients: an immunologic evaluation of Impact. Crit Care Med 1995; 23: 652–659.

    Google Scholar 

  159. Senkal M, Kernen M, Homann H-H, et al. Modulation of postoperative immune response by enteral nutrition with a diet enriched with arginine, RNA, and omega-3 fatty acids in patients with upper gastrointestinal cancer. Eur J Surg 1995; 161: 115–122.

    PubMed  CAS  Google Scholar 

  160. Braga M, Gianotti L, Cestari A, et al. Gut function and immune and inflammatory responses in patients perioperatively fed with supplemented enteral formulas. Arch Surg 1996; 131: 1257–1265.

    PubMed  CAS  Google Scholar 

  161. McCarter MD, Gentilini O, Gomez ME, et al. Preoperative oral supplementation with immunonutrients in cancer patients. JPEN J Parenter Enteral Nutr 1998; 22: 206–211.

    PubMed  CAS  Google Scholar 

  162. Daly JM, Lieberman MD, Goldfine J, et al. Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery 1992; 112: 56–67.

    PubMed  CAS  Google Scholar 

  163. Daly JM, Weintraub FN, Shou J, et al. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg 1995; 221: 327–338.

    PubMed  CAS  Google Scholar 

  164. Koretz RL. Immunonutrition [letter]. Surgery 1993; 114: 631.

    PubMed  CAS  Google Scholar 

  165. Fainsinger RL, Grämlich LM. How often can we justify parenteral nutrition in terminally ill cancer patients? J Palliat Care 1997; 13: 48–51.

    PubMed  CAS  Google Scholar 

  166. Howard L. Home parenteral nutrition in patients with a cancer diagnosis. JPEN J Parenter Enteral Nutr 1992; 16: 93S - 99S.

    PubMed  CAS  Google Scholar 

  167. August DA, Thorn D, Fisher RL, et al. Home parenteral nutrition for patients with inoperable malignant bowel obstruction. JPEN J Parenter Enteral Nutr 1991; 15: 323–327.

    PubMed  CAS  Google Scholar 

  168. King LA, Carson LF, Konstantinides RN, et al. Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience? Gynecol Oncol 1993; 51: 377–382.

    PubMed  CAS  Google Scholar 

  169. Cozzaglio L, Balzola F, Cosentino F, et al. Outcome of cancer patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr 1997; 21: 339–342.

    PubMed  CAS  Google Scholar 

  170. Baines M, Oliver DJ, Carter RI. Medical management of intestinal obstruction in patients with advanced malignant disease: a clinical and pathological study. Lancet 1985; 2: 990–993.

    PubMed  CAS  Google Scholar 

  171. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981; 66: 1191–1308.

    PubMed  CAS  Google Scholar 

  172. Willett WC. Diet, nutrition, and avoidable cancer. Environ Health Perspect 1995; 103 (suppl 8): 165–170.

    PubMed  Google Scholar 

  173. Hill MJ. Diet and cancer: a review of scientific evidence. Eur J Cancer Prev 1995; 4 (suppl 2): 3–42.

    PubMed  Google Scholar 

  174. Ziegler RG, Hoover RN, Pike MC, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993; 85: 1819–1827.

    PubMed  CAS  Google Scholar 

  175. Schatzkin A. Dietary change as a strategy for preventing cancer. Cancer Metastasis Rev 1997; 16: 377–392.

    PubMed  CAS  Google Scholar 

  176. Chesson A, Collins A. Assessment of the role of diet in cancer prevention. Cancer Lett 1997; 114: 237–245.

    PubMed  CAS  Google Scholar 

  177. Ames BN. Dietary carcinogens and anticarcinogens. Science 1983; 221: 1256–1264.

    PubMed  CAS  Google Scholar 

  178. Strickland PT, Kensler TW. Chemical and physical agents in our environment. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE, eds. Clinical Oncology. New York: Churchill Livingstone, 1995: 151–166.

    Google Scholar 

  179. Weindruch R, Albanes D, Kritchevsky D. The role of calories and caloric restriction in carcinogenesis. Hematol Oncol Clin North Am 1991, 79–89.

    Google Scholar 

  180. Caporaso NE, Tucker MA, Hoover RN, et al. Lung cancer and the debrisoquine metabolic phenotype. J Natl Cancer Inst 1990; 82: 1264–1272.

    PubMed  CAS  Google Scholar 

  181. Weindruch R. Caloric restriction and aging. Sei Am 1996; 274: 46–52.

    CAS  Google Scholar 

  182. Trichopoulos D, Li FP, Hunter DJ. What causes cancer? Sei Am 1996; 275: 80–87.

    CAS  Google Scholar 

  183. Greenwald P. Chemoprevention of cancer. Sei Am 1996; 275: 96–99.

    CAS  Google Scholar 

  184. Singh DK, Lippman SM. Cancer chemoprevention, part I: retinoids and carotenoids and other classic antioxidants. Oncology 1998; 12: 1643–1658.

    PubMed  CAS  Google Scholar 

  185. Albright CD, Liu R, Mar M-H, et al. Diet, apoptosis, and carcinogenesis. Adv Exp Med Biol 1997; 422: 97–107.

    PubMed  CAS  Google Scholar 

  186. Wachsman JT. The beneficial effects of dietary restriction: reduced oxidative stress and enhanced apoptosis. Mutat Res 1996; 350: 25–34.

    PubMed  Google Scholar 

  187. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med 1995; 333: 677–685.

    PubMed  CAS  Google Scholar 

  188. Bostick RM. Diet and nutrition in the etiology and primary prevention of colon cancer. In: Bendich A, Deckelbaum RJ. eds. Preventive Nutrition. In: The Comprehensive Guide for Health Professionals. Totowa, NJ: Humana Press, 1997: 57–95.

    Google Scholar 

  189. Singh DK, Lippman SM. Cancer chemoprevention, part 2: hormones, nonclassic antioxidant natural agents, NSAIDs, and other agents. Oncology 1998; 12: 1787–1800.

    PubMed  CAS  Google Scholar 

  190. Weisburger JH, Williams GM. Causes of cancer. In: Murphy GP, Lawrence W, Lenhard, RE Jr, eds. American Cancer Society Textbook of Clinical Oncology. Atlanta: American Cancer Society, 1995: 10–39.

    Google Scholar 

  191. Eisenberg DM, Kessler RC, Foster C, et al. Unconventional medicine in the United States: prevalence, costs, and patterns of use. N Engl J Med 1993; 328: 246–252.

    PubMed  CAS  Google Scholar 

  192. Cassileth BR, Chapman CC. Alternative cancer medicine: a ten-year update. Cancer Invest 1996; 14: 396–404.

    PubMed  CAS  Google Scholar 

  193. Angell M, Kassirer JP. Alternative medicine—the risks of untested and unregulated remedies. N Engl J Med 1998; 339: 839–841.

    PubMed  CAS  Google Scholar 

  194. DiPaola RS, Zhang H, Lambert GH, et al. Clinical and biologic activity of an estrogenic herbal combination (PPC-SPES) in prostate cancer. N Engl J Med 1998; 339: 785–791.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. David A. August
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of California, San Francisco, USA

    Jeffrey A. Norton MD (Professor and Vice-Chairman of Surgery, Chief) (Professor and Vice-Chairman of Surgery, Chief)

  2. Surgical Service, San Francisco VA Medical Center, San Francisco, California, USA

    Jeffrey A. Norton MD (Professor and Vice-Chairman of Surgery, Chief) (Professor and Vice-Chairman of Surgery, Chief)

  3. Division of General Surgery, Duke University Medical Center, Durham, North Carolina, USA

    R. Randal Bollinger MD, PhD (Professor of Surgery, Professor of Immunology, Chief) (Professor of Surgery, Professor of Immunology, Chief)

  4. Division of Surgical Oncology, University of Michigan, Comprehensive Cancer Center, Ann Arbor, Michigan, USA

    Alfred E. Chang MD (Chief, Hugh Cabot Professor of Surgery) (Chief, Hugh Cabot Professor of Surgery)

  5. Department of Surgery, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA

    Stephen F. Lowry MD (Professor and Chairman) (Professor and Chairman)

  6. Division of General Surgery, University of California, San Francisco, San Francisco, California, USA

    Sean J. Mulvihill MD (Professor of Surgery, Chief) (Professor of Surgery, Chief)

  7. Karmanos Cancer Institute, Wayne State University, Harper Hospital, Detroit, Michigan, USA

    Harvey I. Pass MD (Professor of Surgery and Oncology, Chief of Thoracic Oncology) (Professor of Surgery and Oncology, Chief of Thoracic Oncology)

  8. Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri, USA

    Robert W. Thompson MD (Associate Professor of Surgery) (Associate Professor of Surgery)

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

August, D.A. (2001). Nutritional Care of Cancer Patients. In: Norton, J.A., et al. Surgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57282-1_84

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57282-1_84

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-63239-6

  • Online ISBN: 978-3-642-57282-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation